Cumulative incidence of relapse in children with standard-risk ALL according to MRD levels at the end of remission induction.

All patients were in complete morphologic remission at the time of the MRD studies. Levels of MRD were defined by the percentage of mononuclear cells expressing leukemia-specific immunophenotypes.